Atlas Trials

iDentification and vAlidation Model of Liquid biopsY Based cfDNA Methylation and pRotEin biomArKers for Pancreatic Cancer (DAYBREAK Study)

Clinical trial NCT05495685 · UNKNOWN

Trial details

NCT number
NCT05495685
Sponsor
Changhai Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Cancer
Start date
2022-03-24
Primary completion
2023-12-31
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.